Diagnostic accuracy of quantitative faecal immunochemical test in symptomatic patients for the investigation of colorectal cancer once accounting for anaemia severity and iron deficiency

IF 2.9 3区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Colorectal Disease Pub Date : 2025-02-07 DOI:10.1111/codi.70024

James Lucocq, Emma Barron, Heather Holmes, Peter D. Donnelly, Neil Cruickshank

{"title":"Diagnostic accuracy of quantitative faecal immunochemical test in symptomatic patients for the investigation of colorectal cancer once accounting for anaemia severity and iron deficiency","authors":"James Lucocq, Emma Barron, Heather Holmes, Peter D. Donnelly, Neil Cruickshank","doi":"10.1111/codi.70024","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aim</h3>\n \n <p>The aim of this study was to determine the diagnostic accuracy of the faecal immunochemical test (FIT) for colorectal cancer (CRC) in symptomatic patients with different levels of anaemia severity or the presence of iron deficiency.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>Symptomatic patients (2018–2021) from primary care were followed up prospectively for CRC for 2 years. The positive predictive values (PPV) for CRC of FIT subgroups were compared between anaemia severity groups and iron deficiency groups once stratified for symptom type and demographics. The diagnostic accuracy of FIT for CRC was investigated for different definitions of iron deficiency anaemia (IDA).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 17 538 symptomatic patients were investigated, including 310 with CRC (1.8%). In FIT < 100 μg haemoglobin (Hb)/g subgroups, the PPV for CRC was unchanged between anaemia severity levels (<i>p</i> > 0.05). In groups with FIT < 100 μg Hb/g, the PPV for CRC was unchanged in the presence of IDA, non-iron-deficiency anaemia and iron deficiency without anaemia (<i>p</i> > 0.05). In the anaemia and IDA subgroups investigated, FIT 10–19 μg Hb/g had a PPV of <3% for CRC and increasing the FIT cut-off to 20 μg Hb/g could have hypothetically saved 28.6% of colonoscopies. Including transferrin saturation in the definition of IDA increased the detection of CRC in FIT-negative patients (sensitivity 9.1% vs. 3.9%) but with a low CRC pick-up rate (PPV = 0.6%; 165 colonoscopies per CRC). Investigating FIT-negative functional IDA would increase the detection of CRC by 1.3% but with a PPV of 0.5%.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The diagnostic accuracy of FIT is excellent regardless of the severity of anaemia, iron deficiency, symptom type or demographics. The FIT cut-off can be increased safely to 20 μg Hb/g irrespective of anaemia severity or iron deficiency. Altering the definition of IDA does not pragmatically increase the detection of CRC in negative/low FIT patients.</p>\n </section>\n </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 2","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Disease","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/codi.70024","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Aim

The aim of this study was to determine the diagnostic accuracy of the faecal immunochemical test (FIT) for colorectal cancer (CRC) in symptomatic patients with different levels of anaemia severity or the presence of iron deficiency.

Method

Symptomatic patients (2018–2021) from primary care were followed up prospectively for CRC for 2 years. The positive predictive values (PPV) for CRC of FIT subgroups were compared between anaemia severity groups and iron deficiency groups once stratified for symptom type and demographics. The diagnostic accuracy of FIT for CRC was investigated for different definitions of iron deficiency anaemia (IDA).

Results

A total of 17 538 symptomatic patients were investigated, including 310 with CRC (1.8%). In FIT < 100 μg haemoglobin (Hb)/g subgroups, the PPV for CRC was unchanged between anaemia severity levels (p > 0.05). In groups with FIT < 100 μg Hb/g, the PPV for CRC was unchanged in the presence of IDA, non-iron-deficiency anaemia and iron deficiency without anaemia (p > 0.05). In the anaemia and IDA subgroups investigated, FIT 10–19 μg Hb/g had a PPV of <3% for CRC and increasing the FIT cut-off to 20 μg Hb/g could have hypothetically saved 28.6% of colonoscopies. Including transferrin saturation in the definition of IDA increased the detection of CRC in FIT-negative patients (sensitivity 9.1% vs. 3.9%) but with a low CRC pick-up rate (PPV = 0.6%; 165 colonoscopies per CRC). Investigating FIT-negative functional IDA would increase the detection of CRC by 1.3% but with a PPV of 0.5%.

Conclusion

The diagnostic accuracy of FIT is excellent regardless of the severity of anaemia, iron deficiency, symptom type or demographics. The FIT cut-off can be increased safely to 20 μg Hb/g irrespective of anaemia severity or iron deficiency. Altering the definition of IDA does not pragmatically increase the detection of CRC in negative/low FIT patients.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Colorectal Disease 医学-胃肠肝病学

CiteScore

6.10

自引率

11.80%

发文量

406

审稿时长

1.5 months

期刊介绍： Diseases of the colon and rectum are common and offer a number of exciting challenges. Clinical, diagnostic and basic science research is expanding rapidly. There is increasing demand from purchasers of health care and patients for clinicians to keep abreast of the latest research and developments, and to translate these into routine practice. Technological advances in diagnosis, surgical technique, new pharmaceuticals, molecular genetics and other basic sciences have transformed many aspects of how these diseases are managed. Such progress will accelerate. Colorectal Disease offers a real benefit to subscribers and authors. It is first and foremost a vehicle for publishing original research relating to the demanding, rapidly expanding field of colorectal diseases. Essential for surgeons, pathologists, oncologists, gastroenterologists and health professionals caring for patients with a disease of the lower GI tract, Colorectal Disease furthers education and inter-professional development by including regular review articles and discussions of current controversies. Note that the journal does not usually accept paediatric surgical papers.